Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Identification of novel reproducible combinatorial genetic risk factors for myalgic encephalomyelitis in the DecodeME patient cohort and commonalities with long COVID.

Journal of translational medicine·2026
Same author

Single-cell RNA sequencing of appendiceal adenocarcinoma reveals a low proportion of epithelial cells and a fibroblast enriched tumor microenvironment.

ESMO gastrointestinal oncology·2026
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Anisotropy driven spin-reorientation, and two-step magnetic ordering in cubic semiconducting spinelCr0.1Mn0.9Fe0.2Co1.8O4.

Journal of physics. Condensed matter : an Institute of Physics journal·2025

Related Experiment Video

Updated: Feb 20, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform.

C Gilson1, S Chowdhury2, M K B Parmar1

  • 1MRC Clinical Trials Unit at UCL, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|October 29, 2017
PubMed
Summary
This summary is machine-generated.

Advanced prostate cancer treatments show progress. Early chemotherapy (docetaxel) and abiraterone improve outcomes, with ongoing research exploring molecular targets within the STAMPEDE trial.

Keywords:
Biomarkersclinical trial designplatform trialsprecision medicineprostate cancer

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K

Related Experiment Videos

Last Updated: Feb 20, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.9K

Area of Science:

  • Oncology
  • Medical research

Background:

  • Advanced prostate cancer treatment has seen recent advancements.
  • Conventional androgen deprivation therapy is a standard treatment.

Purpose of the Study:

  • To evaluate the efficacy of upfront chemotherapy (docetaxel) and abiraterone in advanced prostate cancer.
  • To explore new therapeutic approaches based on molecular biology insights.

Main Methods:

  • The multi-arm, multi-stage (MAMS) STAMPEDE protocol was utilized.
  • The study involved ongoing recruitment and testing of hypotheses.

Main Results:

  • Upfront docetaxel demonstrated additional benefits over conventional androgen deprivation.
  • Abiraterone also showed significant benefits when administered upfront.

Conclusions:

  • Early administration of docetaxel and abiraterone improves outcomes in advanced prostate cancer.
  • Understanding molecular heterogeneity is key to developing novel therapies within trials like STAMPEDE.